<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>&#x682A;&#x5F0F;&#x4F1A;&#x793E;&#x30DE;&#x30A4;&#x30AF;&#x30ED;&#x30F3;</provider_name><provider_url>https://microncro.com</provider_url><author_name>info@digitalcube.jp</author_name><author_url>https://microncro.com/archives/post/author/infodigitalcube-jp/</author_url><title>An Introduction to Our Collaboration with Overseas Startup Companies | Micron, Inc. | Molecular Imaging CRO Network</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="O1yHjHEB6y"&gt;&lt;a href="https://microncro.com/en/archives/post/news20250325/"&gt;An Introduction to Our Collaboration with Overseas Startup Companies&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://microncro.com/en/archives/post/news20250325/embed/#?secret=O1yHjHEB6y" width="600" height="338" title="&#x201C;An Introduction to Our Collaboration with Overseas Startup Companies&#x201D; &#x2014; &#x682A;&#x5F0F;&#x4F1A;&#x793E;&#x30DE;&#x30A4;&#x30AF;&#x30ED;&#x30F3;" data-secret="O1yHjHEB6y" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://microncro.com/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><description>Micron, Inc. and Meracle Pte Ltd. (Head Office: Singapore) are featured on i2.JP, a healthcare open innovation network operated by AstraZeneca K.K., as a collaboration case study. In the interview, they discuss the challenges faced by foreign companies in understanding Japanese regulations and the efforts made in partnership with Micron to bring medical device products [&hellip;]</description><thumbnail_url>https://microncro.com/wp-content/uploads/2026/05/OGP_W1200_H630.png</thumbnail_url><thumbnail_width>1200</thumbnail_width><thumbnail_height>630</thumbnail_height></oembed>
